Quote:
Originally Posted by Rain Man
Out of curiosity, why? I was just looking into that stock.
|
Bristol-Myers Squibb Stock Is Falling as Celgene Deal Is Delayed. ... Shares of the company dropped sharply in pre-market trading, after a triple whammy of bad news for the firm, which is in the midst of a $74 billion acquisition of Celgene (ticker: